{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:12:28Z","timestamp":1788527548186,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eprac.2026.08.013","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:48:37Z","timestamp":1787068117000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two-Year Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth With Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Extended Follow-Up"],"prefix":"10.1016","author":[{"given":"Yael","family":"Lebenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5342-9626","authenticated-orcid":false,"given":"Talia","family":"Jacobi-Polishook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirli","family":"Abiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kineret","family":"Mazor-Aronovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avivit","family":"Brener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Ben Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neriya","family":"Levran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3801-8970","authenticated-orcid":false,"given":"Noah","family":"Levek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8701-5218","authenticated-orcid":false,"given":"Avigail","family":"Wittenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Rachmiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Pinhas-Hamiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-3250","authenticated-orcid":false,"given":"Noah","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2026.08.013_bib1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1159\/000543034","article-title":"International society for pediatric and adolescent diabetes clinical practice consensus guidelines 2024: diabetes technologies \u2014 insulin delivery","volume":"97","author":"Biester","year":"2024","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.013_bib2","first-page":"546","article-title":"International society for pediatric and adolescent diabetes clinical practice consensus guidelines 2024: glycemic targets","volume":"97","author":"de Bock","year":"2024","journal-title":"Horm Res Paediatr"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.08.013_bib3","first-page":"S283","article-title":"14. Children and adolescents: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.013_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/dia.2021.0319","article-title":"Safety and glycemic outcomes during the MiniMed advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes","volume":"24","author":"Carlson","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.013_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.013_bib6","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/dom.14714","article-title":"Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: evidence from 12,870 real-world users","volume":"24","author":"Arrieta","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2026.08.013_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110052","article-title":"Long-term outcomes of an advanced hybrid closed-loop system: a focus on different subpopulations","volume":"191","author":"Beato-V\u00edbora","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.013_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13300-023-01501-6","article-title":"Safety, metabolic and psychological outcomes of medtronic MiniMed 780G in children, adolescents and young adults: a systematic review","volume":"15","author":"Passanisi","year":"2024","journal-title":"Diabetes Ther"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.013_bib9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/dc23-2311","article-title":"Sustained effectiveness of an advanced hybrid closed-loop system in a cohort of children and adolescents with type 1 diabetes: a 1-year real-world study","volume":"47","author":"Passanisi","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.013_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/dia.2023.0433","article-title":"Celebrating the data from 100,000 real-world users of the MiniMed 780G system in Europe, Middle East, and Africa collected over 3 years: from data to clinical evidence","volume":"26","author":"Choudhary","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.013_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/dia.2023.0081","article-title":"MiniMed 780G advanced hybrid closed-loop system outcomes according to pubertal status: awesome study group real-life experience","volume":"25","author":"Rachmiel","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.013_bib12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/dia.2024.0148","article-title":"Real-life achievements of MiniMed 780G advanced closed-loop system in youth with type 1 diabetes: awesome study group multicenter prospective trial","volume":"26","author":"Gruber","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.013_bib13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for CGM data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.013_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/dia.2022.0491","article-title":"MiniMed 780G six-month use in children and adolescents with type 1 diabetes: clinical targets and predictors of optimal glucose control","volume":"25","author":"Lombardo","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2026.08.013_bib15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1177\/19322968221085273","article-title":"A Glycemia Risk Index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings","volume":"17","author":"Klonoff","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.013_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1932296819838525","article-title":"Evaluating glucose control with a novel composite continuous glucose monitoring index","volume":"14","author":"Leelarathna","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2026.08.013_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/dc23-1581","article-title":"Time in tight glucose range in T1D: predictive factors and achievable targets","volume":"47","author":"Castaneda","year":"2024","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.013_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/pedi.13195","article-title":"Dual diagnosis of type 1 diabetes mellitus and attention deficit hyperactivity disorder","volume":"22","author":"Mazor-Aronovitch","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.eprac.2026.08.013_bib19","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.2337\/dc20-3097","article-title":"Understanding metabolic memory: the prolonged influence of glycemia during the DCCT on future risks of complications","volume":"44","author":"Lachin","year":"2021","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2026.08.013_bib20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/pedi.13440","article-title":"Long-term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes","volume":"23","author":"Piccini","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.eprac.2026.08.013_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1332418","article-title":"Glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system: 2-year prospective, observational, two-center study","volume":"15","author":"Seget","year":"2024","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.013_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/15209156251376708","article-title":"Long-term glycemic outcomes in pediatric type 1 diabetes: a 2-year real-world analysis of different automated insulin delivery system generations","volume":"28","author":"L\u00fchrs","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.013_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an International consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2026.08.013_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/dia.2023.0112","article-title":"Advanced hybrid closed loop improves GRI, COGI, and TIR in children with T1D","volume":"25","author":"Eviz","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.013_bib25","first-page":"178","article-title":"Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes","volume":"43","author":"Cobry","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.013_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/dom.70410","article-title":"What is the impact of an advanced hybrid closed-loop system on weight control among people with type 1 diabetes?","volume":"28","author":"Koning","year":"2026","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.013_bib27","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.2337\/dc23-0204","article-title":"Insulin omission for weight loss in a female adolescent treated with advanced hybrid closed-loop system: a word of caution","volume":"46","author":"Levek","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.08.013_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13300-023-01501-6","article-title":"Safety, metabolic and psychological outcomes of medtronic MiniMed 780G\u2122 in children, adolescents and young adults: a systematic review","volume":"15","author":"Passanisi","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.eprac.2026.08.013_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3842","article-title":"Efficacy and safety of different hybrid closed loop systems for automated insulin delivery in people with type 1 diabetes: a systematic review and network meta-analysis","volume":"40","author":"Di Molfetta","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.eprac.2026.08.013_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-8587(25)00091-9","article-title":"Efficacy and safety of automated insulin delivery in children aged 2\u20136 years (LENNY): an open-label, multicentre, randomised, crossover trial","volume":"13","author":"Battelino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2026.08.013_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/dom.70228","article-title":"One-year effectiveness and safety in young children aged 2\u20136 years with type 1 diabetes using an automated insulin delivery system: a real-world prospective cohort study","volume":"28","author":"De Meulemeester","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2026.08.013_bib32","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400185","article-title":"Automated insulin delivery for young people with type 1 diabetes and elevated A1c","volume":"3","author":"Boucsein","year":"2024","journal-title":"NEJM Evid"},{"key":"10.1016\/j.eprac.2026.08.013_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/cod.12866","article-title":"Allergic contact dermatitis caused by isobornyl acrylate in freestyle\u00ae libre, a newly introduced glucose sensor","volume":"77","author":"Herman","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.eprac.2026.08.013_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/dia.2019.0236","article-title":"High prevalence of skin reactions among pediatric patients with type 1 diabetes using new technologies: the alarming role of colophonium","volume":"22","author":"Lombardo","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.08.013_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15264","article-title":"Real-world lived experience of older adults with type 1 diabetes after an automated insulin delivery trial","volume":"41","author":"Kubilay","year":"2024","journal-title":"Diabet Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:14:21Z","timestamp":1788524061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26011146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S1530891X26011146"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.013","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-Year Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth With Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Extended Follow-Up","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}